Skip to main navigation Skip to search Skip to main content

Rational treatment of fibromyalgia for a solo practitioner

  • Eduardo S. Paiva
  • , Kim Dupree Jones

    Research output: Contribution to journalReview articlepeer-review

    Abstract

    Fibromyalgia (FM) is a challenging condition, but the management of patients with FM is becoming facilitated by new medications that act in what are thought to be some of most important pathophysiological features in this syndrome. However, it is of pivotal importance that an interdisciplinary approach is used to improve pain, fatigue, sleep and other domains to improve quality of life. Here, we present elements of management that the solo practitioner can tackle, focussing in the formally approved drugs for FM and other drugs commonly used in this condition. Further, the elements of an ideal multidisciplinary team are presented, and on how to incorporate their recommendations for the treatment of FM.

    Original languageEnglish (US)
    Pages (from-to)341-352
    Number of pages12
    JournalBest Practice and Research: Clinical Rheumatology
    Volume24
    Issue number3
    DOIs
    StatePublished - Jun 2010

    Funding

    Dr. Jones has received FM-related grant funding from National Institutes of Health (NIH), Pfizer, Schwarz, Jazz and Merck and she acts as a consultant and/or speakers bureaus for Pfizer, Lilly, Forrest and Jazz.

    Funders
    Schwarz Pharma
    Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health
    Pfizer

      Keywords

      • fibromyalgia
      • interdisciplinary management

      ASJC Scopus subject areas

      • Rheumatology

      Fingerprint

      Dive into the research topics of 'Rational treatment of fibromyalgia for a solo practitioner'. Together they form a unique fingerprint.

      Cite this